Severe mitral regurgitation requiring surgery is the most common life-threatening complication of mitral valve prolapse (MVP) , and 1:28 (22-41), respectively. In women, the risk was less than half that in men (p<0.001). We conclude that the risk of developing severe mitral regurgitation is age and sex related, is minimal before the age of 50, and rises sharply after the age of 50, particularly in men, and that the current minimum number of patients requiring myxomatous mitral valve surgery in Australia is between 150 and 200 per year, a caseload that will increase with the advancing age of the population. The findings are consistent with the predictions of a response-to-injury hypothesis that explains the pathogenesis of progressive changes in the prolapsing mitral valve. (Circulation 1988;78:10-14) P rimary mitral valve prolapse, as opposed to that secondary to a systemic disorder of connective tissue or to a reduction in left ventricular cavity size, occurs with a prevalence of 2.5-5% in the adult population, according to recent surveys using careful clinical and echocardiographic diagnostic criteria. [1] [2] [3] [4] It is relatively uncommon before the growth spurt of adolescence,5,6 but thereafter, the prevalence in men remains relatively constant. Most studies have found a greater prevalence in women than in men, and among women, there are data suggesting a greater prevalence in adolescence and young adulthood. 1,4 (However,
P rimary mitral valve prolapse, as opposed to that secondary to a systemic disorder of connective tissue or to a reduction in left ventricular cavity size, occurs with a prevalence of 2.5-5% in the adult population, according to recent surveys using careful clinical and echocardiographic diagnostic criteria. [1] [2] [3] [4] It is relatively uncommon before the growth spurt of adolescence,5,6 but thereafter, the prevalence in men remains relatively constant. Most studies have found a greater prevalence in women than in men, and among women, there are data suggesting a greater prevalence in adolescence and young adulthood. 1, 4 (However, some of the findings of early studies1 may have been influenced by the use of less strict diagnostic criteria.)
Mitral valve prolapse is largely benign,7 and serious complications are uncommon, the most frequent being severe mitral regurgitation requiring valve surgery.8-10 This complication, which occurs in a small subset of patients with mitral valve prolapse, is due to progressive myxomatous changes in the valve, wvhich eventually lead to marked regurgitation.l1011 In about 75% of these patients, there is sudden deterioration because of chordal rupture. [8] [9] [10] [11] Increased awareness of the prevalence of mitral valve prolapse and improved diagnostic methods have led to its frequent identification in young adults. Because the occurrence of severe mitral regurgitation increases with age, 3, 6, 8, 11, 12 2 These data provide support for the figure of 4% prevalence in men and for the risks we have estimated for men. However, as Levy and Savage' point out, had more rigid diagnostic criteria been adopted in the Framingham study, the prevalence in men would have been in the range of 1-2%. If that figure is applicable to our population, the risk in men would be approximately double that which we have calculated.
With regard to women, the prevalence data are less clear. The Framingham study found a 13.7% prevalence among 591 women between the ages of 20 and 40 years with a striking decline thereafter to 1.4% at the age of 80 and over.4 Our own figure among 100 Australian women of mean age ± SD of 38 ± 10 years (range, 18-57 years) was 4%.2 This is similar to the 5.6% recently found by Devereux et a13 among healthy American women. It is noteworthy that the Framingham series contained a high proportion of silent mitral valve prolapse (about 80%) and that the criteria for the diagnosis of pansystolic prolapse, the usual reason for a falsepositive diagnosis, were less rigid than our own.2 Moreover, when diagnostic criteria similar to our own are applied to the Framingham data in women, Levy and Savage1 estimate an actual prevalence in the range of 3-4%. While we felt that a 4% prevalence figure for women was the most appropriate one to use for our calculations, if the true preva-lence is higher, then the already low risk of surgery for women will be even smaller than we have estimated.
It is possible that those patients with silent mitral valve prolapse [i.e., the echocardiographic features described above (see "Materials and Methods")] in the absence of nonejection clicks or mitral murmurs (usually young patients, in our experience6) would not be at risk of progressive changes. The proportion of patients with silent mitral valve prolapse among those identified in our population surveys was 31%--nine of the 29 patients with mitral valve prolapse so identified. 
